Tag Archives: stocks

Botanix Pharmaceuticals Limited (ASX:BOT) is a Perth-based company. Its main asset is Sofpironium Bromide (SOFDRA), which it aims to use as a treatment for Primary Axillary Hyperhidrosis (PAH). It does have two other programs that have completed a Phase 1/2 trial; however, they are on hold until the commercialisation of Sofpironium Bromide. Sofpironium Bromide, orContinue reading “FDA making us sweat”